Could Your Genes Predict How Well You'll Do on a GLP-1? A New Study Says Maybe

If you've watched someone melt weight off on the same medication that barely budged your scale — or sail through with no nausea while you struggled — you've witnessed one of the most frustrating realities of GLP-1s: response varies enormously from person to person. A new study suggests part of the explanation may be written in your genes.

We're sharing this as a hopeful glimpse of where the science is heading, not as something you can act on today. It's genuinely fascinating, and it may eventually make choosing the right medication far more personalized. Let's look at what the researchers found.

Using a large genetic dataset from 23andMe and publishing in Nature, researchers identified genetic variants associated with two things: how much weight people lose on GLP-1s, and how likely they are to experience nausea. The ranges were striking — roughly 6–20% for weight loss and a remarkable 5–78% for nausea risk, depending on genotype.

Those wide ranges are the headline. They suggest that some people are genetically predisposed to strong results with little discomfort, while others sit at the difficult end on both measures — and that a meaningful chunk of the variation we see in clinics may be hereditary.

A 6–20% spread in weight loss is enormous — it's the difference between a modest result and a life-changing one. The data suggest individual response to GLP-1s is partly genetic, which helps explain why two people following the same plan on the same drug can have such different journeys.

The nausea range is even wider, from 5% to 78%. If you've ever felt like the side effects hit you harder than they 'should,' this offers a kind of validation: your biology may genuinely be more sensitive than someone else's. It's not in your head, and it's not a lack of toughness.

Picture a future where, before prescribing, your clinician could check which GLP-1 you're genetically likely to respond to best, and which might make you miserably nauseated. That kind of genetically guided selection could spare a lot of trial-and-error and help match people to the right drug from the start.

We have to be honest, though: that future isn't standard practice yet. These findings are early and need more validation before they reshape how medications are chosen. For now, prescribing still relies on clinical judgment and a bit of trial-and-error — but the direction of travel is encouraging.

This study helps explain something many people have felt but couldn't name: that response to GLP-1s is deeply individual, and partly genetic. The wide ranges for both weight loss and nausea suggest your genes play a real role in your experience.

It's not a tool you can use in the clinic today, but it's a hopeful sign of more personalized care to come. In the meantime, if a medication isn't working or is making you sick, that's worth discussing with your provider — switching is reasonable, and your individual biology is a legitimate reason to do so.